- OSI-7904L
-
OSI-7904L is a novel noncompetitive liposomal thymidylate synthase inhibitor. Its effect on solid tumours is currently under evaluation.[1]
References
- ^ Ricart AD, Berlin JD, Papadopoulos KP, et al. (December 2008). "Phase I, pharmacokinetic and biological correlative study of OSI-7904L, a novel liposomal thymidylate synthase inhibitor, and cisplatin in patients with solid tumors". Clin. Cancer Res. 14 (23): 7947–55. doi:10.1158/1078-0432.CCR-08-0864. PMID 19047127.
This antineoplastic or immunomodulatory drug article is a stub. You can help Wikipedia by expanding it.